Robaxin (methocarbamol) NDC 0641-6103

NDC codes

FDA NDC Directory

Product NDC (as listed)0641-6103Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00641-6103Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0641-6103-10	00641610310	10 VIAL in 1 CARTON (0641-6103-10) / 10 mL in 1 VIAL (0641-6103-01)Marketed from Oct 4, 2023
0641-6103-25	00641610325	25 VIAL in 1 CARTON (0641-6103-25) / 10 mL in 1 VIAL (0641-6103-01)Marketed from Jun 16, 1959

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Robaxin
Generic name (nonproprietary): methocarbamol
Active ingredients: Methocarbamol — 100 mg/mL
Dosage form: Injection
Route: Intramuscular, Intravenous
Labeler: Hikma Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 011790
Marketing start: Jun 16, 1959
Listing expires: Dec 31, 2026
Other FDA classes: Centrally-mediated Muscle Relaxation (Physiologic effect)
Identifiers: Product ID 0641-6103_086ede61-af0e-4f2d-a51d-75a4c1d9f2a0SPL ID 086ede61-af0e-4f2d-a51d-75a4c1d9f2a0SPL set ID 090a3d3d-92c3-4c30-a648-436461f81702RxCUI 207014, 238175UNII 125OD7737X
Pharmacologic class: Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400641610310 followed by a unit qualifier and the quantity

Package 00641-6103-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 10, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE The injectable form of methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 011790

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 011790
Product	Strength	Form · route	Labeler	Product NDC
Robaxinmethocarbamol	Methocarbamol 100 mg/mL	InjectionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0641-6217